Cargando…
Novel intergenic KIF5B-MET fusion variant in a patient with gastric cancer: A case report
BACKGROUND: MET fusion is a key driver mutation, but it is rare in gastric cancer (GC). Several MET (hepatocyte growth factor receptor) inhibitors have been approved for the treatment of MET-positive patients, but the tumor response is heterogeneous. With the development of next-generation sequencin...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107910/ https://www.ncbi.nlm.nih.gov/pubmed/34002144 http://dx.doi.org/10.12998/wjcc.v9.i14.3350 |